Price Fishback, Takeshi Inomata, Chris Segrin, Kathy Short and Todd Vanderah are the University of Arizona's newest Regents Professors. The university's highest faculty rank honors exceptional achievements that merit national and international recognition

Todd Vanderah, PhD, professor and department head of the University of Arizona College of Medicine – Tucson’s Department of Pharmacology, was named an Alumni of the Year for 2023 by the University of Arizona Alumni Foundation.

Dr. Todd Vanderah professor and department head of the University of Arizona College of Medicine – Tucson’s Department of Pharmacology, was named an Alumni of the Year for 2023 by the University of Arizona Alumni Foundation.

Dr. Mohab Ibrahim always knew he wanted to be a doctor; his lived experience and mentors helped him find his calling as a pain specialist and researcher. Working on new ways to treat pain, he collaborates around UArizona and with BIO5 faculty.

Researchers at two state universities are joining forces to battle the opioid epidemic with help from decades of chemistry research conducted by Purdue Pharma.

A new partnership between academic medical centers at UArizona and Oklahoma State University involves sharing research assets and knowledge, as well as the preclinical and clinical expertise.

Throughout his career spent studying opioids Dr.Todd Vanderah has been determined to find a way to manage pain without increasing the risk of addiction.

UArizona researchers in the Comprehensive Pain and Addiction Center are seeking new therapies for migraine in an unlikely place – the endogenous cannabinoid system.

A new paraprofessional program, Project FUTRE, trains people to become family support specialists and help address the needs of loved ones with substance use disorders.

The Center of Excellence for Addiction Studies at UArizona Health Sciences is tackling the opioid crisis through the development of new collaborative research and support for faculty interested in pursuing research in addiction studies.

Collaborative efforts that will be fostered through the new Center of Excellence for Addiction Studies will be vital to help find solutions to end the opioid epidemic.

A cannabinoid acid may keep COVID-19 from entering human cells by targeting the virus’s spike protein.

Dr. Todd Vanderah of the College of Medicine Tucson shares how his passion of building has led him to his current place in life.

Studies are revealing how people responded to changes brought about by the pandemic. UArizona pharmacology professor Dr. Todd Vanderah talks about the reported link between COVID-19 isolation and an increase in substance abuse.

A new UArizona Health Sciences Workforce Education and Training Program, PeerWORKS, has been designed to help people impacted by opioid and substance use disorders.

Dr. Todd Vanderah addresses what you need to know if you are thinking about trying CBD.

More than 1.5B people live with chronic pain worldwide, the most common cause of long-term disability in the US, and several BIO5 researchers are addressing the issue tackling the opioid epidemic using basic science and clinical approaches.